Search Items: Lymphocytes - immunology , . hits: 11
** Jursik, C; Prchal, M; Grillari-Voglauer, R; Drbal, K; Fuertbauer, E; Jungfer, H; Albert, WH; Steinhuber, E; Hemetsberger, T; Grillari, J; Stockinger, H; Katinger, H Large-scale production and characterization of novel CD4+ cytotoxic T cells with broad tumor specificity for immunotherapy..
** Kittel, C; Ferko, B; Kurz, M; Voglauer, R; Sereinig, S; Romanova, J; Stiegler, G; Katinger, H; Egorov, A Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment..
** Mascola, JR; Lewis, MG; VanCott, TC; Stiegler, G; Katinger, H; Seaman, M; Beaudry, K; Barouch, DH; Korioth-Schmitz, B; Krivulka, G; Sambor, A; Welcher, B; Douek, DC; Montefiori, DC; Shiver, JW; Poignard, P; Burton, DR; Letvin, NL Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies..
** Frank, I; Kacani, L; Stoiber, H; Stössel, H; Spruth, M; Steindl, F; Romani, N; Dierich, MP Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious..
** Jahn-Schmid, B; Graninger, M; Glozik, M; Küpcü, S; Ebner, C; Unger, FM; Sleytr, UB; Messner, P Immunoreactivity of allergen (Bet v 1) conjugated to crystalline bacterial cell surface layers (S-layers)..
Immunotechnology. 1996; 2(2):103-113 WoS PubMed** Muster, T; Ferko, B; Klima, A; Purtscher, M; Trkola, A; Schulz, P; Grassauer, A; Engelhardt, OG; García-Sástre, A; Palese, P Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus..
** Buchacher, A; Predl, R; Strutzenberger, K; Steinfellner, W; Trkola, A; Purtscher, M; Gruber, G; Tauer, C; Steindl, F; Jungbauer, A Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization..
AIDS Res Hum Retroviruses. 1994; 10(4):359-369 WoS PubMed* Chen, YH; Susanna, A; Böck, G; Steindl, F; Katinger, H; Dierich, MP (1994): HIV-1 gp41 shares a common immunologic determinant with human T, B and monocyte cell lines..
Immunol Lett. 1994; 39(3):219-222 PubMedChen, YH; Susanna, A; Steindl, F; Katinger, H; Dierich, MP (1994): HIV-1 gp41 shares a common immunologic determinant with normal human blood lymphocytes and monocytes..
AIDS. 1994; 8(1):130-131 PubMed** Muster, T; Guinea, R; Trkola, A; Purtscher, M; Klima, A; Steindl, F; Palese, P; Katinger, H Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS..
** Grunow, R; Jahn, S; Porstmann, T; Kiessig, SS; Steinkellner, H; Steindl, F; Mattanovich, D; Gürtler, L; Deinhardt, F; Katinger, H The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus..
J Immunol Methods. 1988; 106(2):257-265 WoS PubMed